A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.
about
The epidermal growth factor receptor conundrum.A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 studyDocetaxel in the treatment of breast cancer: current experience and future prospects.Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy.Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?A clinical phase II study of a non-anthracycline sequential combination of cisplatin-vinorelbine followed by docetaxel as first-line treatment in metastatic breast cancer.Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer.Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.
P2860
Q35942163-101330B2-AE40-411C-8B82-C21ACCA28A1CQ35994850-C7137515-44B2-47AF-9A7B-15739C9EF470Q36235546-A5C0E9EF-D2D8-41DF-B76F-674A00C2F5C5Q36769011-12703F6D-89F8-4483-8755-E8B41A4F9867Q37196395-CA1A018D-1086-4993-B4A4-85B863ECA0B5Q38195674-19F54DBD-4993-405F-8240-554961671E24Q40462502-9FE2AC57-F10A-48DC-A7DA-1FF54D52D10BQ42113569-5A5B5FA1-AE71-4A7F-87DB-23664DC7C6BDQ47130842-1E94A8BA-025E-45F0-87A6-41386477A668
P2860
A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A randomized phase II study of ...... with metastatic breast cancer.
@en
A randomized phase II study of ...... with metastatic breast cancer.
@nl
type
label
A randomized phase II study of ...... with metastatic breast cancer.
@en
A randomized phase II study of ...... with metastatic breast cancer.
@nl
prefLabel
A randomized phase II study of ...... with metastatic breast cancer.
@en
A randomized phase II study of ...... with metastatic breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
A randomized phase II study of ...... with metastatic breast cancer.
@en
P2093
A K Hatfield
J C Michalak
J W Kugler
L Geeraerts
P2860
P304
P356
10.1093/ANNONC/MDF222
P577
2002-08-01T00:00:00Z